Inactive

This is a Sources Sought announcement only. All responses will be used for market research and analysis in determining the availability of potential qualified businesses that may be used to determine ... This is a Sources Sought announcement only. All responses will be used for market research and analysis in determining the availability of potential qualified businesses that may be used to determine appropriate acquisition strategy. No solicitation is being issued at this time but may be issued later. The Charlie Norwood VA Medical Center in Augusta GA is seeking DaTscan radiopharmaceutical injections or an equal product. The period of performance will be for one (1) base year with four, one-year option periods to begin September 28, 2022. The Nuclear Medicine Departments projects that the annual estimate is 20 doses for the first year, and 25 doses for each option year. The vendor must have the capability to receive orders with 72 hours notice and make delivery to the VA Medical Center on the day of use. Interested offerors are encouraged to respond to this notice via e-mail and provide the following information: 1) Company name 2) Company associated SAMS UEI number 3) Company Address and Pharmacy servicing address (if different from company address) 4) Identify whether you are the manufacturer of DaTscan (or equal) 5) If not the manufacturer, provide a letter from manufacturer confirming you are authorized to distribute or resell the drug 6) Proof of current (not expired) license by the United States Nuclear Regulatory Commission This notice will close on Thursday, June 23, 2022, at 10: AM ET. Responses to this notice received after that time will not be included in the market research and analysis. All questions and responses to this notice must be forwarded to Lasonja Harvey via email at lasonja.harvey@va.gov. Please include in the title of the email: RFI 36C24722Q0760-DATSCAN.